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Patterns of change in reward motivation, response inhibition, mood and craving over 
3 months of smoking abstinence 
Lynne Dawkins, Jane H. Powell, Alan Pickering , John Powell and 
Robert West 
ABSTRACT 
Aims: We have previously demonstrated that acute smoking abstinence is associated with 
lowered reward motivation and impaired response inhibition.  This prospective study explores 
whether these impairments, along with withdrawal-related symptoms, recover over three 
months of sustained abstinence.  Design: Participants completed a 12-hour abstinent 
baseline assessment and were then randomly allocated to quit unaided or continue smoking.  
All were re-tested after 7 days, 1 month and 3 months.  Successful quitters’ scores were 
compared with those of continuing smokers, who were tested after ad libitum smoking.  
Setting: Goldsmiths, University of London.  Participants: 33 smokers who maintained 
abstinence to 3 months, and 31 continuing smokers.  Measurements: Indices previously 
demonstrated in this cohort of smokers to be sensitive to the effect of nicotine vs. acute 
abstinence: reward motivation (SHAPS, CARROT, Stroop); tasks of response inhibition 
(antisaccade task; CPT) and clinical indices of mood (HADS), withdrawal symptoms (MPSS) 
and desire to smoke.  Findings: SHAPS anhedonia and reward responsivity (CARROT) 
showed significant improvement and plateaued after a month of abstinence, not differing 
from the scores of continuing smokers tested in a satiated state.  Mood, other withdrawal 
symptoms and desire to smoke all declined from acute abstinence to 1 month of cessation 
and were equivalent, or lower than, the levels reported by continuing, satiated smokers.  
Neither group showed a change in CPT errors over time whilst continuing smokers, but not 
abstainers, showed improved accuracy on the antisaccade task at 3 months.   Conclusion: 
Appetitive processes and related affective states appear to improve in smokers who remain 
nicotine-free for 3 months whereas response inhibition does not.  Although in need of 
replication, the results tentatively suggest that poor inhibitory control may constitute a long-
term risk factor for relapse and could be a target for intervention.  
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INTRODUCTION 
Acute abstinence from regular smoking is associated with somatic symptoms, low mood 
[1,2] motivational and cognitive disturbance [3-7] and impaired inhibitory control [8-10]. 
Which of these dysfunctions develop as a consequence of smoking, or are constitutional 
deficits that predate regular smoking, remains uncertain. If the former is the case, and if 
neuroadaptations are reversible, then such impairments should normalise with continuing 
abstinence; if the latter is the case, they would not be expected to improve even with 
protracted abstinence.  Since the time course and trajectory of such impairments may 
affect the ability of the smoker to maintain abstinence, it is useful to chart their natural 
history.   
 
Very few prospective studies have included measures of cognition.  In one recent study in 
which mental arithmetic was assessed post-cessation [11], scores returned to baseline 
(pre-quit) levels within ten days of quitting.  However, Gilbert and colleagues [12] noted 
reduced accuracy on the rapid visual information processing (RVIP) task and EEG 
deactivation in abstinent smokers which failed to return to either pre-quit baseline, or 
smoking control levels after 31 days.  
 
A handful of cross-sectional studies have compared current, ex, and non-smokers on 
indices of reward motivation and cognition; in some, impairments were demonstrated by 
current smokers but not ex-smokers [13, 14], whilst in others the opposite was found [15].  
Whilst this may reflect the particular tests used, a recent EEG study [16] found 
hypoactivation of the pre-frontal cortex and anterior cingulate in smokers who had been 
abstinent for a mean of 11 years.  
 
With respect to abstinence-related affective and somatic symptoms, nicotine withdrawal is 
characterised by anxiety, depression, irritability, restlessness, difficulty concentrating and 
desire to smoke [1,2].  Early studies suggested that such symptoms recover within a few 
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weeks [17-19]; however, reported durations in recent studies have ranged from less than 
two weeks [20,11] to over a month [21-23].  In one of very few studies which have tracked 
withdrawal symptoms for longer periods, Piasecki and colleagues [24,25] found 
considerable heterogeneity in the profiles of symptoms presented by different individuals 
(75% of whom used a nicotine patch), and approximately 40% showed an increase in the 
severity of withdrawal symptoms after 30 days of abstinence, [24].  In a related study they 
found comparable levels of depression, anhedonia and somatic features (e.g. decreased 
appetite, lack of motivation, impaired sleep) in both current and ex-smokers (abstinent for 
at least 6 months) relative to never-smokers [25].  
 
Prospective studies exploring the time course of abstinence-related responses are, 
however, methodologically complex [26,22]; a major weakness is selective dropout which 
can seriously bias conclusions.  For example, high relapse rates may distort mean scores 
in the residual sample if relapse is more likely in those who experience the greatest 
severity of symptoms or cognitive impairment in the early stages of abstinence.  Relatedly, 
successful abstainers may be characterised by atypical levels of motivation, or may differ 
in other important ways from the broader population of smokers; hence their experience 
may not generalise to all smokers.  In studies which lack a randomly assigned ‘continuing-
to-smoke’ control group, the interpretation of findings may be limited by practice or 
familiarity effects.   
 
The present study explored changes in withdrawal symptoms, mood, reward motivation 
and response inhibition over 3 months of continuous smoking abstinence, comparing 
smokers randomly allocated between ‘quit’ and ‘continue-to-smoke’ conditions. 
 
METHODS 
Participants 
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Smokers were recruited through adverts in local newspapers, radio stations, colleges, 
libraries and pharmacies in the South East London area.  All were aged between 18 and 
65 and smoked ten or more cigarettes a day and within the first hour of waking.  Exclusion 
criteria included current diagnosis of psychiatric or neurological condition, regular use of 
prescription or class A recreational drugs, and pregnancy. All participants gave written 
informed consent and the study was approved by Goldsmiths Ethics Committee. 
 
 
Design & Procedure 
This was part of a larger study [5,8].  145 smokers (57% female; 78% Caucasian) were 
assessed on two occasions after overnight (12 hour) abstinence (confirmed by breath CO 
levels < 11ppm), once after receiving a 4-mg NiQuitin lozenge and once after receiving a 
placebo lozenge (order counterbalanced; procedure double-blind). 
 
Immediately after the second session participants were randomly allocated in a 3:1 ratio 
between ‘quit’ and ‘continue-to-smoke’ conditions.  Those in the quit group were provided 
with written information and advice but were prohibited from using NRT or other 
medications.  Assessments were repeated at 7 days, 1 month and 3 months, and any 
quitters who reported more than one lapse since the last session or who had a salivary 
cotinine level of more than 20 ng/ml were classified as relapsers.  Participants allocated to 
the ‘continue to smoke’ condition were required to smoke a cigarette just before each 
follow-up testing session to ensure that they were tested in a satiated state. 
 
All participants were offered incremental financial incentives for participating in each 
successive assessment, subject to their compliance with the requirement to remain 
abstinent or continue smoking.  Participants did not receive any payment until their final 
assessment.  The maximum payment was £150 for those who attended all 5 sessions. 
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Assessment measures 
Demographic information included age, gender, and years of education. 
 
Baseline smoking-related measures 
 Cigarettes smoked per day (self-report)  
 Salivary cotinine:  Participants provided a saliva sample at a pre-test screening 
session and at each follow-up.  A cut-off of 20 ng/ml was used for verification of non-
smoking status [27]. 
 The Fagerström Test of Nicotine Dependence (FTND) [28]: a six-item self-report scale 
to assess nicotine dependence.  Scores range from 0 (low dependence) to 10 (high 
dependence). 
 
Clinical variables measured at baseline and each follow-up 
 The Hospital Anxiety and Depression Scale (HADS) [29] assesses self-rated anxiety 
and depression over the preceding 7 days.  Total scores range from 0 to 21 for both 
states.  
 Desire to smoke: Participants rated their response to the question ‘how strong is your 
desire to smoke right now? From 1 = not at all strong to 7 = extremely. 
 Mood and Physical Symptoms Scale (MPSS) [30]: Participants rated the severity of 7 
withdrawal-related symptoms on a 0-4 scale ‘at this moment in time’.  The maximum 
score of 28 indicates severe symptoms.  
 
Experimental measures assessed during acute abstinence and at each follow-up  
The full assessment battery is detailed in Dawkins et al. [5].  Here we focus on only those 
indices found in the full sample to be impaired during acute abstinence (i.e. in the placebo 
relative to the nicotine lozenge condition).  Specifically: 
 
Reward Motivation 
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 The Card Arranging Reward Responsivity Objective Test (CARROT) [3].  Participants 
are required to sort cards according to a simple rule under conditions of financial 
reward (R) and no reward (NR) presented over 3 experimental trials in the order NR1, 
R, NR2.  The ‘reward responsivity index’ (RRI), impaired during abstinence,[5] is the 
average card sorting rate (cards per second) under NR subtracted from the average 
card sorting rate under R. 
 Anhedonia: The Snaith-Hamilton pleasure scale (SHAPS) [31] is a 14-item self-report 
scale measuring hedonic tone.  Total score ranges from 0 (not anhedonic) to 42 
(highly anhedonic).   
 Attentional bias to reward cues (modified Stroop) [6].  Participants colour-name the ink 
in which each of 88 words (either neutral or pleasure-related; order counterbalanced) 
are printed.  The neutral words serve as a comparison against which to evaluate the 
interference from the pleasure-related words.  Abstinence reduces bias towards 
pleasure-related relative to neutral words as reflected in number of errors [5].  The 
‘pleasure bias’ index is errors to pleasure-related words minus errors to neutral words; 
we previously found the effect of acute abstinence to affect this error index and not the 
overall speed of colour-naming (see Dawkins et al., [5]).  
 
Response Inhibition 
 Oculomotor antisaccade accuracy [32,33].  Participants are required to suppress a 
reflexive glance towards a peripherally-appearing stimulus and instead generate an 
eye movement (antisaccade) in the opposite direction.  The index impaired during 
acute abstinence [7] and therefore analysed here, is percentage correct.  
 Motor errors in the Continuous Performance Task (CPT) [34].  5-digit numbers are 
presented visually at a constant rate of two per second for five minutes.  Experimental 
stimuli (sequences with no obvious structure, e.g. 97528) are separated one from the 
next by three ‘filler’ stimuli of the fixed sequence 12345.  Participants are required to 
press a button when two consecutive experimental stimuli are identical, and not to 
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 Statistical analysis 
Each variable was subjected to repeated measures ANOVA with the between-subjects 
factor of GROUP (abstainers vs. continuing smokers) and the within-subjects factor of 
OCCASION (acute abstinence as assessed in the baseline placebo lozenge condition; 7 
days; 1 month; 3 months).   Thus whilst both groups were in the same 12-hour abstinent 
state at baseline, in subsequent assessments the continuing smokers were nicotine 
satiated having smoked immediately prior to the assessment session whilst the quit group 
were completely nicotine free.  Since we were specifically interested in comparing the two 
groups’ patterns of change from one occasion to the next, a priori contrasts compared 
scores at adjacent time points (i.e. baseline vs. one week; one week vs. one month; one 
month vs. three months).   
 
Given the high rate of relapse in the quit group (see below) which begins to undermine the 
initial effects of randomization, we have conducted additional 2X4 ANOVAs for each 
variable based on a better-matched sub-group of successful abstainers and continuing 
smokers.  Since pre-baseline salivary cotinine levels were shown to be the single most 
important clinical predictor of abstinent status in this sample (withdrawal symptoms, mood 
or dependence as assessed by the FTND were not significant predictors) [35], we have 
used this variable as a basis for matching.  Thus a cut-off of 330 was employed which 
resulted in the loss of three successful abstainers who were outliers at the high end, and 
eleven continuing smokers.  These additional sub-analyses based on 29 quitters and 20 
smokers matched for salivary cotinine level (quitters mean: 189.5; smokers mean: 179.5; t 
< 1, ns) are also reported in brief to supplement the main findings. 
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RESULTS 
Background and Demographic Information 
Of the 145 participants who completed the baseline assessments [5], 107 were 
randomised to quit; of these 33, (31%) maintained cotinine-verified abstinence at all follow-
ups.  Of the 38 participants allocated to continue smoking, 31 (82%) attended all follow-
ups.  All analyses are based on these two subgroups.  Some data were missing for some 
variables, usually due to calibration or technical problems. Thus, sample sizes vary 
between analyses, from 26 to 33 abstainers and 25 to 31 continuing smokers.  
 
Baseline (acute abstinence) scores for the 33 successful abstainers vs. the 31 continuing 
smokers were compared for all clinical and experimental variables via independent 
samples t-tests.  The groups did not differ in sex ratio, age, years of education, number of 
cigarettes smoked per day, dependence (FTND), pre-baseline salivary cotinine levels, or 
any of the experimental variables (see Table 1). 
 
Insert Table 1 here  
 
 
 
Clinical Variables 
Withdrawal symptoms 
Mean scores are shown in Figure 1.  
 
Insert Fig 1 here 
 
 
There was a significant decline in symptom severity from baseline (acute abstinence) to 
one week (F1,61 = 8.0, p < 0.01), this being more pronounced in the continuing smokers 
(GROUP x OCCASION: F1,61 = 4.4, p < 0.05).  From one week to one month, a significant 
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GROUP x OCCASION interaction (F1,61 = 4.4, p < 0.05) reflects a continued improvement 
in the abstainers versus a slight worsening in the continuing smokers.  Symptoms 
remained stable from one to three months (no main effect of OCCASION nor an 
interaction with GROUP: F1,61 < 1, ns, in both cases).  The groups did not differ 
significantly in the severity of their symptoms at any individual follow-up (t62 < 1.5, ns, in all 
cases).  This pattern of findings was not altered in the better matched sample  
 
Desire to smoke 
Subjective desire to smoke is shown in Figure 2.  
 
Insert Figure 2 here 
 
 
The decline in scores from baseline to one week was significant (F1,62 = 12.5, p = 0.001) 
and similar in both groups (no OCCASION x GROUP interaction: F1,62 < 1, ns).  A further 
significant decline from a week to a month (F1,62 = 19.7, p < 0.001) was qualified by a 
significant GROUP x OCCASION interaction (F1,62 = 4.1, p < 0.05) with abstainers’ scores 
reducing more.  There was no overall further reduction from one to three months, nor any 
interaction with GROUP (F1,62 < 1, ns, in both cases).   
 
Abstainers’ scores were lower than those of the continuing smokers at all follow-up points; 
this difference was just short of significance at one week (t62 = -1.95, p < 0.06) but highly 
significant at both one and three months (t62 = 4.2 and 5.2, p < 0.001).  
 
This pattern of findings remained the same in the better-matched sub-sample. 
 
HADS anxiety 
Anxiety scores are shown in Figure 3.   
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Insert Figure 3 here 
  
ANOVA confirmed a significant reduction from baseline to one week (OCCASION: F1,61 = 
5.7, p = 0.02) with no GROUP x OCCASION interaction (F1,61 < 1, ns).  There was, 
however, a significant GROUP x OCCASION interaction from one week to one month 
(F1,61 = 4.9, p < 0.05) with abstainers showing a further reduction in anxiety but continuing 
smokers an increase.  There was no significant change from one to three months (neither 
a main effect nor interaction: F1,61 < 1, ns). 
 
Although the graph suggests that anxiety was higher in abstainers than continuing 
smokers at one week and vice versa at a month, the groups did not differ significantly at 
any follow-up point (t62 < 1, ns, in all cases). 
 
These findings were essentially replicated in the better-matched sample, although the 
GROUP X OCCASION interaction from one week to one month now fell short of 
significance (F1,46 = 2.78, ns) 
 
HADS depression 
These scores are shown in Figure 4.   
 
Insert Figure 4 here  
 
Mood improved significantly from baseline to one week (F1,62 = 7.7, p < 0.01) and this did 
not interact with GROUP (F1,62 < 1, ns).   
 
A significant GROUP x OCCASION interaction from one week to one month (F1,62 = 6.5, p 
= 0.01), reflects an improvement in the abstainers but if anything a worsening in the 
continuing smokers.  At this point, abstainers were significantly less depressed than 
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continuing smokers (t62 = 2.1, p < 0.05).  From one to three months there was neither a 
main effect of OCCASION nor a GROUP x OCCASION interaction (F1,62 < 1, ns, in both 
cases), though slight changes meant that they no longer differed significantly at this point 
(t62 < 1, ns). 
 
Analyses using the better-matched sample of abstainers and continuing smokers again 
replicated these findings although the main effect of OCCASION from baseline to one 
week now fell short of significance (F1,47 = 2.17, ns)  
 
Reward Motivation 
SHAPS Anhedonia 
Anhedonia scores are shown in Figure 5.   
 
Insert Figure 5 here 
 
There was a significant improvement in hedonic tone from baseline to one week (F1,59 = 
4.9, p < 0.05), not qualified by an interaction with GROUP (F1,59 < 1, ns).  There was no 
subsequent change (all main effects and interactions: F1,59 < 1, ns).  At no time point did 
the two groups differ significantly from each other (t59 < 1, ns, in all cases). 
 
Analysis of the smaller, better-matched sample revealed a similar pattern of results 
although the significant improvement from baseline to one week was now lost (F1,44 = 1.7, 
ns).  
 
CARROT Reward Responsivity 
 
Insert Figure 6 here  
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Reward responsivity increased significantly from baseline to one week (F1,59 = 3.87, p = 
0.05), with no GROUP x OCCASION interaction (F1,59 < 1, ns).   There were no further 
changes across consecutive points (F1,59 < 1, ns, for both main effects and interactions), 
and at no follow-up did the two groups differ from each other (t59 < 1, ns, in all cases; see 
Figure 6). 
 
The same pattern of findings emerged in the better-matched sample but again, the 
improvement from baseline to one week now fell short of significance (F1,45 = 1.0, ns). 
 
Attentional bias towards appetitive words (Stroop) 
There was neither a significant main effect of OCCASION, nor an OCCASION x GROUP 
interaction, for the contrasts between any two consecutive occasions (F1,61 < 1, ns, in all 
cases; Table 2).   These results were unchanged in the better-matched sample. 
 
Response Inhibition 
Oculomotor (antisaccade) task 
 
Insert Figure 7 here  
 
Accuracy fluctuated markedly from one occasion to the next (see Figure 7).  An 
improvement from acute abstinence to one week was significant (F1,50 = 10.9, p < 0.01) 
and greater in the continuing smokers (OCCASION x GROUP: F1,50 = 6.1, p < 0.02).  A 
subsequent decline in accuracy between one week and one month was also significant 
(F1,50 = 4.1, p < 0.05) and did not interact with GROUP (F1,50 < 1, ns).  There was a near-
significant improvement from one to three months (F1,50 = 3.4, p = 0.07), again not 
interacting with GROUP (F1,50 < 1, ns).   At no individual follow-up did the groups differ 
significantly from each other (t50 < 1, ns, in each case).  Given the complexity of this 
pattern, scores at baseline were contrasted directly with those at three months, revealing a 
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significant GROUP x OCCASION interaction (F1,55 = 6.1, p < 0.05) in which continuing 
smokers had improved highly significantly (t27 = 4.0, p <0.0001) whilst abstainers had not 
(t28 < 1, ns). 
 
Analyses of the smaller, better-matched groups again revealed a significant improvement 
from acute abstinence to one week (F1,36 = 4.0, p < 0.05) whilst all other significant main 
effects and interactions now fell short of significance (F1,36 < 2.5, ns in all cases).  
However, the critical interaction from baseline to 3 months remained significant (F1,36 = 
4.11, p < 0.05). 
 
CPT motor errors 
There were no main effects of OCCASION nor any GROUP x OCCASION interactions in 
the full, (F1,50 < 1, ns, in all cases; mean scores given in Table 2) or the better-matched, 
sample. 
 
DISCUSSION 
Consistent with previous reports [17-19], self-reported withdrawal symptoms, anxiety and 
depression steadily improved over one month, whilst in continuing smokers they remained 
relatively stable across three months.  Anxiety and depression scores were well within the 
‘normal’ (non-clinical) range for both groups even during acute abstinence (baseline).   
 
Abstainers’ marked decline in desire to smoke contrasted with the stability shown by 
continuing smokers’ across the three follow-ups.  This profile is consistent Gilbert et al.’s 
findings that craving dropped steadily over the first month of quitting, differing statistically 
from the scores of continuing smokers by days 16-22 [36].  In the present study ratings of 
desire to smoke, mood and physical symptoms were made towards the end of the one-
hour testing session; thus although continuing smokers had smoked immediately prior to 
the session they may have began to experience withdrawal by this point.  Since 
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participants reported smoking an average of 18.5 cigarettes per day (just over one per 
waking hour), their ratings within the session are likely to correspond to their experience at 
many points during a normal day.   
 
Both abstainers’ and continuing smokers’ SHAPS anhedonia scores were lower at the 
one-week follow-up than during acute abstinence, and then remained stable to 3 months.  
The two groups did not differ at any point, and their mean scores fell within the normal 
range on all occasions.  Pomerleau et al. [37] found self-reported anhedonia in ex-
smokers (abstinent for 6 months or more) to be comparable with that in current smokers; 
both groups were more anhedonic than never-smokers.  Thus although the present data 
suggest that any initial abstinence-related decline in hedonic tone rapidly recovers to the 
levels smokers achieve by smoking, in the absence of a matched group of non-smokers it 
is unclear to what extent it truly normalises. 
 
Turning to reward motivation, whilst acute abstinence was characterised by lower baseline 
reward responsivity on the CARROT, this improved equally in the two groups by one 
week. Since performance in the continuing smokers was presumably enhanced by their 
recent nicotine use (consistent with our previous experimental findings [3-5]), the parallel 
improvement by the abstainers is therefore consistent with natural recovery.  However 
practice/familiarity effects may also have contributed to the observed improvements in 
both groups.   
 
With regard to attentional bias to pleasure-related words, there was little change in either 
abstainers or continuing smokers.  In fact, there was no evidence that acute abstinence 
reduced attentional bias to pleasure versus neutral words in the subgroup of successful 
quitters described here, contrasting with our findings in the larger sample of 145 smokers 
[5].  This may reflect the lower statistical power yielded by this smaller sample, or 
alternatively a relative lack of motivational blunting during acute abstinence in smokers 
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who are able to maintain prolonged abstinence.  However it is notable that this same 
subgroup did exhibit diminished reward responsivity on the CARROT during acute 
abstinence.   
  
Finally, abstainers showed no improvement on two indices of response inhibition 
(antisaccade accuracy and motor errors on the continuous performance task [CPT).  
Although neither group showed a change in CPT errors over time, continuing smokers did 
show improved accuracy on the antisaccade task once they had resumed smoking 
reflecting our previous finding [8].  Thus deficits in one index of inhibitory control – 
oculomotor response inhibition - do not appear to recover across three months of 
abstinence.  These findings parallel Neuhaus et al’s observation of abnormally low 
activation of frontal regions in long-term abstainers, [16] and are consistent with the 
existence of long-term deficits in response inhibition.  These may reflect underlying neural 
dysfunctions which predate regular smoking or which are acquired during the course of 
regular smoking which fail to recover within the first few months of cessation.  In either 
event, it could be an indicator of susceptibility to relapse, either because it correlates with 
a difficulty in inhibiting habitual smoking behaviour, or because smokers smoke in part to 
increase control over other their impulsive tendencies.  Interventions to aid smoking 
cessation might therefore usefully focus on strategies for enhancing inhibitory control over 
the longer-term as well as in the initial stages of abstinence. 
  
This study is not without its limitations.  First, although an impressive one-third of smokers 
who were allocated to the quit group managed to abstain for 3 months, this nevertheless 
resulted in a fairly modest sample size of only 33 abstainers.  Second, given that two-
thirds of those allocated to the quit group subsequently relapsed, introduces the possibility 
that the self-selected abstainers showed reduced severity of impairment during acute 
abstinence.  Nevertheless, we have shown in this sample that withdrawal symptoms, 
mood and dependence (on the FTND) did not significantly predict relapse whilst pre-quit 
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salivary cotinine level did [35].  That our supplementary sub-analysis of successful 
abstainers and continuing smokers matched for cotinine levels confirmed the results of the 
full sample, affords us greater confidence in these findings.  Third, it is possible that this 
group of successful abstainers had better emotional regulation ability for genetic or other 
reasons, or experienced fewer environmental stressors during abstinence, both of which 
were not assessed here.  
 
Overall, the findings tentatively suggest that appetitive processes and related affective 
states do improve over three months of abstinence in those smokers who are able to 
remain nicotine-free whilst response inhibition may not. Nevertheless, the sample size and 
findings remain modest and should be treated with caution until they can be replicated in a 
larger and better matched sample.  
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Legend for Figures 
Figure 1: Withdrawal symptoms scores (MPSS) on each assessment occasion for quitters 
and continuing smokers.  Error bars are +/- 1SE 
Figure 2: Ratings of desire to smoke on each assessment occasion for quitters and 
continuing smokers.  Error bars are +/- 1SE 
Figure 3: HADS Anxiety scores on each assessment occasion for quitters and continuing 
smokers.  Error bars are +/- 1SE 
Figure 4: HADS depression scores on each assessment occasion for quitters and continuing 
smokers.  Error bars are +/- 1SE 
Figure 5: SHAPS anhedonia scores on each assessment occasion for quitters and 
continuing smokers (high score = greater anhedonia).  Error bars are +/- 1SE 
Figure 6: Reward Responsivity scores on the CARROT on each assessment occasion for 
quitters and continuing smokers.  Error bars are +/- 1SE 
Figure 7:  Antisaccade percentage correct on each assessment occasion for quitters and 
continuing smokers.  Error bars are +/- 1SE 
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Table 1: Means and (SD) for smoking-related, clinical and experimental variables assessed 
at baseline (acute abstinence) for abstainers and continuing-smokers 
 
Variable 
    
 
Mean (SD) 
 
 
t 
 
p 
Age 
   Abstainers 
   Smokers 
 
34.36 (12.56) 
34.54 (14.07) 
 
-0.06 
 
0.96 
Gender (M:F) 
   Abstainers 
   Smokers 
 
15:18 
15:16 
 
0.55 
 
0.81 
Years in education (post 16) 
   Abstainers 
   Smokers 
 
4.86 (4.04) 
3.35 (2.95) 
 
1.70 
 
0.10 
No. of cigarettes/day  
   Abstainers 
   Smokers 
 
17.84 (5.88) 
18.48 (6.27) 
 
-0.42 
 
0.68 
Baseline cotinine 
   Abstainers 
   Smokers 
 
216.45 (120.94) 
272.76 (155.77) 
 
-1.61 
 
0.11 
FTND 
   Abstainers 
   Smokers 
 
4.58 (1.66) 
5.29 (1.81) 
 
-1.65 
 
0.11 
HADS anxiety 
   Abstainers 
   Smokers 
 
7.12 (3.62) 
6.71 (3.49) 
 
0.46 
 
0.65 
HADS depression 
   Abstainers 
   Smokers 
 
4.79 (3.30) 
4.16 (3.03) 
 
0.79 
 
0.43 
Desire to smoke 
   Abstainers 
   Smokers 
 
3.73 (1.64) 
4.29 (1.63) 
 
-1.37 
 
0.18 
 
MPSS 
   Abstainers 
   Smokers 
 
6.56 (4.33) 
8.00 (4.36) 
 
-1.31 
 
0.19 
CARROT reward responsivity 
   Abstainers 
   Smokers 
 
-0.00 (0.08) 
-0.016 (0.06) 
 
0.90 
 
0.37 
 
SHAPS anhedonia 
   Abstainers 
   Smokers 
 
10.74 (5.65) 
11.16 (6.75) 
 
-0.27 
 
0.79 
Stoop interference index 
   Abstainers 
   Smokers 
 
-0.15 (1.42) 
0.10 (1.42) 
 
-0.70 
 
0.49 
Antisaccade accuracy (%) 
   Abstainers 
   Smokers 
 
67.88 (22.82) 
64.05 (15.87) 
 
0.76 
 
0.45 
CPT motor errors 
   Abstainers 
   Smokers 
 
4.20 (3.63) 
6.11 (5.66) 
 
-1.53 
 
0.13 
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Table 2: Means and (SD)s for the ‘interference index’ (pleasure – neutral errors) on the Stroop task and motor errors on the Continuous 
Performance Task (CPT) 
 
 
Variable 
 
Baseline  
(acute abstinence) 
 
7 days 
 
1 month 
 
3 months 
Stroop interference index 
   Quitters 
   Smokers 
 
-0.15 (1.42) 
0.10 (1.42) 
 
0.03 (1.29) 
-0.30 (1.58) 
 
0.15 (1.54) 
-0.07 (1.14) 
 
0.00 (1.37) 
0.13 (1.31) 
CPT motor errors 
   Quitters 
   Smokers 
 
4.44 (3.75) 
5.48 (5.27) 
 
5.22 (6.12) 
5.84 (5.05) 
 
5.07 (5.25) 
5.72 (5.47) 
 
5.85 (6.27) 
6.28 (6.37) 
 
 
